Latest Articles & Resources FEATURED WuXi Biologics’ Hebei Facility Passes FDA Pre-License Inspection for Autoimmune Therapy Read More » WuXi Biologics’ Hebei Facility Passes FDA Pre-License Inspection for Autoimmune Therapy Read More » LATEST NEWS + INTERVIEWS Olon Doubles Production Capacity at Concord Manufacturing Facility NetraMark Signs First CRO-Channelled Contract to Apply NetraAI Platform to Phase 2 Neurodegeneration Trial Data ProPharma Deploys Proprietary AI Capability to Accelerate ANDA Submission Development for Regulatory CRO Clients Axplora’s Leverkusen Site Earns Platinum EcoVadis Rating The Rezon Bio Story: Interview with Dr. Adriana Kiedzierska-Mencfeld Altruist Biologics Receives Trilateral Approval for ADC Manufacturing at Hangzhou Site Porton Advanced Announces FDA Filing Acceptance for UC-MSC Cell Bank DMF RoslinCT Partners with BlueRock Therapeutics to Expand Access to Clinical-Grade Stem Cell Lines Fujifilm Biotechnologies Selected for FDA PreCheck Pilot Program at Holly Springs Facility Evonik Invests US$100 Million to Expand Indiana API CDMO Manufacturing A Category 5 Super Typhoon Is Tracking Toward 630 China and Taiwan Pharma Manufacturing Sites Catalent Expands Partnership With Nanoscope Therapeutics to Support MCO-010 Commercial Supply Mikart Appoints Darrin Schellin as Chief Executive Officer CDMO World Cup: Comparing Global Contract Manufacturing Powerhouses CNR Research Posts Record CRO Order Backlog as Overseas Contracts and AI Platform Transition Drive Growth Matica Biotechnology Partners with VaxDome to Advance Hybrid Antiviral Vaccine Candidates Codis Acquires Catalent’s UK Facility to Expand Oral Solid Dose CDMO Services 6 CMC Strategies Are Transforming Biologics Drug Development Besins Healthcare Acquires UniD Manufacturing to Expand Long-Acting Drug Delivery Capabilities Lonza Acquires Nona Biosciences’ Blood-Brain Barrier Technology for CNS Therapies Shantha Biologics Signs Fill-Finish Manufacturing Agreement with Novo Nordisk PODCAST INTERVIEWS The Rezon Bio Story: Interview with Dr. Adriana Kiedzierska-Mencfeld 6 CMC Strategies Are Transforming Biologics Drug Development Strategic Procurement: How To Build Win-Win CDMO Alliances Beyond Price
NetraMark Signs First CRO-Channelled Contract to Apply NetraAI Platform to Phase 2 Neurodegeneration Trial Data
ProPharma Deploys Proprietary AI Capability to Accelerate ANDA Submission Development for Regulatory CRO Clients
CNR Research Posts Record CRO Order Backlog as Overseas Contracts and AI Platform Transition Drive Growth
